Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2008
06/12/2008WO2008069283A1 Pharmaceutical composition for external application and adhesive skin patch
06/12/2008WO2008069262A1 Film-coated preparation having improved stability
06/12/2008WO2008069020A1 Method for improving solubility of protein, method for stabilizing dissolved state of protein-containing aqueous solution, and composition
06/12/2008WO2008068885A1 Protecting agent for use in lyophilization and method for production of physiologically active substance
06/12/2008WO2008068778A2 Extended release pharmaceutical composition of pramipexole
06/12/2008WO2008068777A2 Stable lercanidipine formulation
06/12/2008WO2008068770A2 Pharmaceutical composition containing bicalutamide and a method for its use
06/12/2008WO2008068731A1 Extended release formulations of carvedilol
06/12/2008WO2008068727A2 Pharmaceutical composition comprising candesartan cilexetil
06/12/2008WO2008068584A2 A heterogeneously configured multiparticulate gastrointestinal drug delivery system
06/12/2008WO2008068577A2 Pharmaceutical compositions
06/12/2008WO2008068471A1 New non-abusable pharmaceutical composition comprising opioids
06/12/2008WO2008068418A2 Textile and/or fiber processing method using an active ingredient composed of nanoparticles<0}
06/12/2008WO2008068417A2 Control and/or monitoring method for the salting-out of at leat one active ingredient impregnated in a textile<0}
06/12/2008WO2008068299A2 Hydrobromide salt of an anti-hiv compound
06/12/2008WO2008068276A1 Soft gelatin capsules comprising acetylsalicylic acid
06/12/2008WO2008068246A1 Liquid anti-rabies antibody formulations
06/12/2008WO2008068230A1 Anaplerotic therapy of huntington disease and other polyglutamine diseases
06/12/2008WO2008067865A1 Package
06/12/2008WO2008067829A1 New modules, new assemblage kits and new assemblies for the controlled release of substances
06/12/2008WO2008067774A1 An antimycotic pharmaceutical composition
06/12/2008WO2008067670A1 Tablets comprising entacapone and crospovidone
06/12/2008WO2008067613A1 Liposome production
06/12/2008WO2008054874A9 Particles with high uniform loading of nanoparticles and methods of preparation thereof
06/12/2008WO2008052033A3 Ibuprofen composition
06/12/2008WO2008049633A3 Spray-freeze-drying process for the preparation of pellets comprising percolation drying
06/12/2008WO2008049178A8 Stable and ready-to-use oil-in-water propofol microemulsion
06/12/2008WO2008049020A3 Diclofenac gel
06/12/2008WO2008046799A3 Preparation of granules of hydrophilic vitamins
06/12/2008WO2008043601A3 Transdermal therapeutic system with two-phase releasing profile
06/12/2008WO2008042970A3 Chitosan-coated calcium sulfate based medicament delivery system
06/12/2008WO2008040799A3 Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release
06/12/2008WO2008039987A3 Methods of treating pulmonary distress
06/12/2008WO2008036809A3 Methods and materials for reducing risk of cold and/or flu
06/12/2008WO2008025425A9 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
06/12/2008WO2008008596A3 Method of reducing inflammation
06/12/2008WO2007148230A3 Grafted polymers and uses thereof
06/12/2008WO2007132344A3 Controlled release compositions of an antidepressant agent
06/12/2008WO2007118653A3 Nanoparticle containing nicotine and/or cotinine, dispersions and use thereof
06/12/2008WO2007112433A3 Compositions for promoting hair growth
06/12/2008WO2007107304A3 An efficient method for loading amphoteric liposomes with nucleic acid active substances
06/12/2008WO2007106550A3 Methods and compositions for deterring abuse of orally administered pharmaceutical products
06/12/2008WO2007072218A3 Formulations containing glimepiride and/or its salts
06/12/2008US20080140036 Antimicrobial Composition
06/12/2008US20080139669 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
06/12/2008US20080139654 Lower dosage; combined with glutathione production promoter; formulated to decrease emesis
06/12/2008US20080139652 Pharmaceutical Composition Containing Prostaglandin
06/12/2008US20080139649 Fatty Acid-Benzenediol Derivatives and Methods of Making and Using Thereof
06/12/2008US20080139645 Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents
06/12/2008US20080139624 Pellets; sustained release
06/12/2008US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents
06/12/2008US20080139519 Applying moist heat to a suspension of a labile glucocorticosteroid, in particular, budesonide or beclomethasone dipropionate, for a sterilizing-effective time; for preventing, reversing, and/or reducing symptoms of allergic and/or inflammatory conditions
06/12/2008US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum
06/12/2008US20080139496 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections
06/12/2008US20080139392 Linker-Based Lecithin Microemulsion Delivery Vehicles
06/12/2008US20080138877 Device which utilizes electrical pulse to make membranes porous to bioactive agents; drug delivery; gene therapy
06/12/2008US20080138501 Forming active material of copper/indium/gallium/selenium or sulfur as ink for solar cells by reacting a solution of non-oxide compounds and capping agent; annealing to form nanoparticles 1-500nm diameter; narrow size distribution; close packing; uniformity; polycrystalline; quality; high quality films
06/12/2008US20080138492 Comletely-Soluble Solid Particle(s) Based on Dietary Fibre(s)
06/12/2008US20080138445 Pharmaceutical mixture for Hepatitis treatment and its preparation method
06/12/2008US20080138437 Reduce toxicity while maintaining efficacy; mix with particulate hydroxyapatite as an auxiliary agent; alkylating agent, antimetabolite, an antitumor antibiotic, plant preparation, hormone preparation, immunotherapeutic agent, cisplatin; injection, infusion, oral administration
06/12/2008US20080138431 Microparticle; poly-lactide biodegradable polymer; polyuridylic acid immunogenic single-stranded ribonucleic acid; recombinant Protective Antigen of Bacillus anthracis biologically active macromolecule; cationic polymer or cationic lipid stabilizing agent; mucosal administration via inhaler; parenteral
06/12/2008US20080138430 Gold sulfide core, gold shell; interpenetrating polymer network of polyacrylic acid, polyacrylamide; irradiate particles with Nd Yag laser to effect temperature induced swelling; near infrared light passes easily and harmlessly through the body
06/12/2008US20080138429 Coated Particles and Pharmaceutical Dosage Forms
06/12/2008US20080138428 Fast-Disintegrating Microporous Binders
06/12/2008US20080138427 Reduced variation in the dissolution profile of a biologically active substance; pharmaceutical, drug sprayed while spraying a binding liquid to the cores; centrifugal fluidized bed coating granulation machine set to1.5 g/cm2
06/12/2008US20080138426 Remedies for sex hormone dependent disease
06/12/2008US20080138425 Method for the Preparation of a Stable Lactate Metal Salt in Powder Form and Stable Metal Lactate Salt
06/12/2008US20080138424 Fibrate particles having average particle size of less than 2000 nm; and a surface stabilizer; reduced fed/fasted variability
06/12/2008US20080138423 Systems and methods for effecting cessation of tobacco use
06/12/2008US20080138422 Analgesic agents, controlled release to provide a rapid onset of analgesic effect, also delayed and/or sustained release; amitriptyline, gabapentin; sleep disorders
06/12/2008US20080138421 And a stabilizer of xylitol, sorbitol, polydextrose, isomalt, dextrose; gel matrix; urinary incontinence, urinary urge incontinence, imperative urinary urge, and/or increased urinary frequency
06/12/2008US20080138420 Microencapsulation Product and Process
06/12/2008US20080138419 Method for preparing an orally administrable formulation for controlled release
06/12/2008US20080138418 Drug delivery polymers from n-butyl cyanoactylate and 2-octyl cyanoacrylate
06/12/2008US20080138417 Topical Composition And Method Of Forming
06/12/2008US20080138416 Method and systems for using biopolymer-based beads and hydrogels
06/12/2008US20080138415 Composition and method for producing composition for constructing tissue, and tissue construct
06/12/2008US20080138413 N-benzyl-N-[3-(1H-indol-5-yl)-benzyl]-N',N'-dimethyl-ethane-1,2-diamine; sleep disorders
06/12/2008US20080138412 Sustained release alfuzosin hydrochl formulation and method for their production
06/12/2008US20080138411 Release rate controlling polymer, diluent, binder, lubricant,surfactant, solubilizing agent, bioavailability enhancer, acidifying agent; depression, depressive disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder
06/12/2008US20080138410 Coated tablet; an active ingredient, excipient, a swellable composition and a reactive composition; a water insoluble polymer surrounding the core, and leachable component
06/12/2008US20080138409 Olanzapine pharmaceutical composition
06/12/2008US20080138408 Drug delivery system and method
06/12/2008US20080138407 Capsule medication administration system and medication administration method
06/12/2008US20080138406 Composition for treatment of pain in bones and joints
06/12/2008US20080138405 Sirolimus having a particle size of more than 400 nm and a surface modifier
06/12/2008US20080138404 Extended release formulations of carvedilol
06/12/2008US20080138403 Pharmaceutical dosage forms of oxcarbazepine
06/12/2008US20080138402 Highly inhibited starch fillers for films and capsules
06/12/2008US20080138401 Delivery vehicle comprising a modified MscL protein channel
06/12/2008US20080138400 Curcumin analog or metabolite microencapsulated by a polyethylene glycolated liposome of dimyristoyl phosphatidylcholine, cholesterol, and dimyristoyl phsphatidylethanolamine; anticarcinogenic and antiproliferative agents; parenteral colloidal drug delivery system providing improved bioavailability
06/12/2008US20080138399 Dual release nicotine formulations, and systems and methods for their use
06/12/2008US20080138398 Dual release nicotine formulations, and systems and methods for their use
06/12/2008US20080138397 Processes for taste-masking of inhaled formulations
06/12/2008US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis
06/12/2008US20080138395 Reduced glutathione or certain thiol derivatives of glutathione in combination with anthocyans or anthocyanidins
06/12/2008US20080138394 Composite For Liver-Specific Delivery and Release of Therapeutic Nucleic Acids or Drugs
06/12/2008US20080138393 Water soluble extract of spinach for prevention and repair of DNA damage
06/12/2008US20080138392 For maintaining or restoring a mitochondrial membrane and/or mitochondrial function; phosphatidylcholine; tetraoleoyl-cardiolipin; methylgentisate, l-carnosine
06/12/2008US20080138391 Skin-friendly drug complexes for transdermal administration
1 ... 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 ... 2991